Cita APA

Bedikian, A. Y., DeConti, R. C., Conry, R., Agarwala, S., Papadopoulos, N., Kim, K. B., & Ernstoff, M. (2011). Phase 3 study of docosahexaenoic acid–paclitaxel versus dacarbazine in patients with metastatic malignant melanoma. Ann Oncol.

Citación estilo Chicago

Bedikian, A. Y., R. C. DeConti, R. Conry, S. Agarwala, N. Papadopoulos, K. B. Kim, y M. Ernstoff. "Phase 3 Study of Docosahexaenoic Acid–paclitaxel Versus Dacarbazine in Patients With Metastatic Malignant Melanoma." Ann Oncol 2011.

Cita MLA

Bedikian, A. Y., et al. "Phase 3 Study of Docosahexaenoic Acid–paclitaxel Versus Dacarbazine in Patients With Metastatic Malignant Melanoma." Ann Oncol 2011.